Browse > Article

Structural Characterization of Mouse HAUSP, a Proteolysis Regulator of p53  

Lee, Hye-Jin (Graduate School of Life Science and Biotechnology, Cell and Gene Therapy Research Institute, Pochon CHA University, CHA General Hospital)
Yoo, Kyong-Jai (Graduate School of Life Science and Biotechnology, Cell and Gene Therapy Research Institute, Pochon CHA University, CHA General Hospital)
Baek, Kwang-Hyun (Graduate School of Life Science and Biotechnology, Cell and Gene Therapy Research Institute, Pochon CHA University, CHA General Hospital)
Publication Information
Animal cells and systems / v.8, no.3, 2004 , pp. 205-212 More about this Journal
Abstract
The tumor suppressor protein p53 is stabilized by the herpes-virus-associated ubiquitin-specific protease (HAUSP), a deubiquitinating enzyme. We previously isolated and characterized a mouse orthologue of HAUSP, mHAUSP. mHAUSP cDNA consisted of 3,312 bp encodes 1,103 amino acids with a molecular weight of approximately 135 kDa containing highly conserved Cys, Asp (I), His, and Asn/Asp (II) domains. In this study, we carried out site-directed mutagenesis of 6 conserved amino acids (Cys224, Gln231, Asp296, His457, His465, and Asp482) in Cys box, QQD box, and His box. Interestingly, the conserved Gln 231 was not essential for the catalytic activity of mHAUSP. However, the other conserved amino acids were required for deubiquitinating activity of mHAUSP. We performed isopeptidase assay and confirmed that mHAUSP is able to remove ubiquitin from ubiquitinated substrates. In addition, we observed that mHAUSP induces apoptosis in HeLa cells.
Keywords
Apoptosis; Deubiquitinating enzyme; HAUSP; p53; Ubiquitin;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Vugmeyster Y, Borodovsky A, Maurice MM, Maehr R, Furman MH, and Ploegh HL (2002) The ubiquitin-proteasome pathway in thymocyte apoptosis: caspase-dependent processing of the deubiquitinating enzyme USP7 (HAUSP). Mol Immunol 39: 431-441   DOI   ScienceOn
2 Wilkinson KD (2000) Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. Semin Cell Dev Biol 11: 141-148   DOI   ScienceOn
3 Sui G, Affar el B, Shi Y, Brignone C, Wall NR, Yin P, Donohoe M, Luke MP, Calvo D, Grossman SR, and Shi Y (2004) Yin Yang 1 is a negative regulator of p53. Cell 117: 859-872   DOI   ScienceOn
4 Quesada V, Diaz-Perales A, Gutierrez-Fernandez A, Garabaya C, Cal S, and Lopez-Otin C (2004) Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases. Biochem Biophys Res Commun 314: 54-62   DOI   ScienceOn
5 Salomoni P and Pandolfi PP (2002) p53 De-ubiquitination: at the edge between life and death. Nat Cell Biol 4: E152-153   DOI   ScienceOn
6 Lim SK, Shin JM, Kim YS, and Baek KH (2004) Identification and characterization of murine mHAUSP encoding a deubiquitinating enzyme that regulates the status of p53 ubiquitination. Int J Oncol 24: 357-364
7 Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J, and Gu W (2002) Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416: 648-653   DOI   ScienceOn
8 Menard R, Carriere J, Laflamme P, Plouffe C, Khouri HE, Vernet T, Tessier DC, Thomas DY, and Storer AC (1991) Contribution of the glutamine 19 side chain to transition-state stabilization in the oxyanion hole of papain. Biochemistry 30: 8924-8928   DOI   ScienceOn
9 Pickart CM (2001) Mechanisms underlying ubiquitination. Annu Rev Biochem 70: 503-533   DOI   ScienceOn
10 Li M, Brooks CL, Kon N, and Gu W (2004) A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol Cell 13: 879-886   DOI   ScienceOn
11 Kim JH, Park KC, Chung SS, Bang O, and Chung CH (2003) Deubiquitinating enzymes as cellular regulators. J Biochem 134: 9-18   DOI   ScienceOn
12 Layfield R, Alban A, Mayer RJ, and Lowe J (2001) The ubiquitin protein catabolic disorders. Neuropathol Appl Neurobiol 27: 171-179   DOI   ScienceOn
13 Honda R, Tanaka H, and Yasuda H (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420: 25-27   DOI   ScienceOn
14 Hu M, Li P, Li M, Li W, Yao T, Wu JW, Gu W, Cohen RE, and Shi Y (2002) Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 111: 1041-1054   DOI   ScienceOn
15 Kubbutat MH, Jones SN, and Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387: 299-303   DOI   ScienceOn
16 Glickman MH and Ciechanover A (2002) The ubiquitinproteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82: 373-428
17 Haupt Y, Maya R, Kazaz A, and Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299   DOI   ScienceOn
18 Hershko A and Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67: 425-479   DOI   ScienceOn
19 Cummins JM and Vogelstein B (2004) HAUSP is required for p53 destabilization. Cell Cycle 3: 689-692
20 Ciechanover A (1998) The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J 17: 7151-7160   DOI   ScienceOn
21 Everett RD, Meredith M, Orr A, Cross A, Kathoria M, and Parkinson J (1997) A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J 16: 1519-1530   DOI   ScienceOn
22 Freiman RN and Tjian R (2003) Regulating the regulators: lysine modifications make their mark. Cell 112: 11-17   DOI   ScienceOn
23 Appella E and Anderson CW (2000) Signaling to p53: breaking the posttranslational modification code. Pathol Biol 48: 227-245
24 Baek KH, Kim MS, Kim YS, Shin JM, and Choi HK (2004) DUB1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes. J Biol Chem 279: 2368-2376   DOI   ScienceOn
25 Chau V, Tobias JW, Bachmair A, Marriott D, Ecker DJ, Gonda DK, and Varshavsky A (1989) A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 243: 1576-1583   DOI